Fig. 2From: Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trialFlow chart of subjects. Number of study participants enrolled, allocated, followed, and analyzed, shown using the CONSORT 2010 Flow Diagram. FAS, full analysis setBack to article page